+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 58 Pages
  • May 2023
  • GlobalData
  • ID: 4225267
Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentators, moisture analyzers, filters, bioreactors, shakers, virus purification kits and centrifuges, among others. SSB's services include bioprocess development and engineering, protein expression systems, media and process, instrument and validation services. The company's products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, France.

Sartorius Stedim Biotech SA Key Recent Developments

Apr 20, 2023: Sartorius Stedim Biotech announces first-quarter results 2023
Mar 27, 2023: Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A. Joachim Kreuzburg remains Chairman of the Board
Mar 15, 2023: Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
Aug 09, 2022: Sartorius to acquire UK's Albumedix for $501.5m

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Sartorius Stedim Biotech SA - Key Facts
  • Sartorius Stedim Biotech SA - Key Employees
  • Sartorius Stedim Biotech SA - Key Employee Biographies
  • Sartorius Stedim Biotech SA - Major Products and Services
  • Sartorius Stedim Biotech SA - History
  • Sartorius Stedim Biotech SA - Company Statement
  • Sartorius Stedim Biotech SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Sartorius Stedim Biotech SA - Business Description
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: EMEA
  • Performance
  • R&D Overview
  • Sartorius Stedim Biotech SA - Corporate Strategy
  • Sartorius Stedim Biotech SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Sartorius Stedim Biotech SA - Strengths
  • Sartorius Stedim Biotech SA - Weaknesses
  • Sartorius Stedim Biotech SA - Opportunities
  • Sartorius Stedim Biotech SA - Threats
  • Sartorius Stedim Biotech SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Sartorius Stedim Biotech SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 20, 2023: Sartorius Stedim Biotech announces first-quarter results 2023
  • Mar 27, 2023: Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A. Joachim Kreuzburg remains Chairman of the Board
  • Mar 15, 2023: Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
  • Aug 09, 2022: Sartorius to acquire UK’s Albumedix for $501.5m
  • Jul 21, 2022: Sartorius Stedim Biotech of Half-year results 2022
  • Apr 21, 2022: Sartorius Stedim Biotech Announces First-quarter results 2022
  • Feb 17, 2022: Sartorius Stedim Biotech presents annual report for 2021
  • Jan 27, 2022: Preliminary results 2021 of Sartorius Stedim Biotech
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Sartorius Stedim Biotech SA, Key Facts
  • Sartorius Stedim Biotech SA, Key Employees
  • Sartorius Stedim Biotech SA, Key Employee Biographies
  • Sartorius Stedim Biotech SA, Major Products and Services
  • Sartorius Stedim Biotech SA, History
  • Sartorius Stedim Biotech SA, Subsidiaries
  • Sartorius Stedim Biotech SA, Key Competitors
  • Sartorius Stedim Biotech SA, Ratios based on current share price
  • Sartorius Stedim Biotech SA, Annual Ratios
  • Sartorius Stedim Biotech SA, Interim Ratios
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Sartorius Stedim Biotech SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sartorius Stedim Biotech SA, Performance Chart (2018 - 2022)
  • Sartorius Stedim Biotech SA, Ratio Charts
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Danaher Corp
  • Qiagen Marseille SA
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA